This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Sep 20;34(27):3235-6.

doi: 10.1200/JCO.2016.68.4050. Epub 2016 Aug 15.

Is Underutilization of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer Contributing to Inferior Survival?

Ana M Molina¹, Jim Hu², David M Nanus²

Affiliations

PMID: 27528717
DOI: 10.1200/JCO.2016.68.4050

Editorial

Is Underutilization of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer Contributing to Inferior Survival?

Ana M Molina et al. J Clin Oncol. 2016.

. 2016 Sep 20;34(27):3235-6.

doi: 10.1200/JCO.2016.68.4050. Epub 2016 Aug 15.

Authors

Ana M Molina¹, Jim Hu², David M Nanus²

Affiliations

¹ Weill Cornell Medicine, New York, NY amm9052@med.cornell.edu.
² Weill Cornell Medicine, New York, NY.

PMID: 27528717
DOI: 10.1200/JCO.2016.68.4050

No abstract available

PubMed Disclaimer

Comment on

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.
Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL, de Velasco G, Trinh QD, Choueiri TK. Hanna N, et al. J Clin Oncol. 2016 Sep 20;34(27):3267-75. doi: 10.1200/JCO.2016.66.7931. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325852 Free PMC article.

Similar articles

Cytoreductive nephrectomy for favorable risk patients with metastatic renal cell carcinoma? No, cytoreductive nephrectomy should no longer be routinely performed.
Kim HL. Kim HL. Curr Opin Urol. 2020 Sep;30(5):743-745. doi: 10.1097/MOU.0000000000000812. Curr Opin Urol. 2020. PMID: 32732627 No abstract available.
Cytoreductive nephrectomy for metastatic renal cell carcinoma.
Chery LJ, Karam JA, Wood CG. Chery LJ, et al. Clin Adv Hematol Oncol. 2016 Sep;14(9):696-703. Clin Adv Hematol Oncol. 2016. PMID: 27673288 Review.
Cytoreductive nephrectomy in metastatic renal cancer - less is more.
Bex A, Haanen J. Bex A, et al. Nat Rev Clin Oncol. 2018 Oct;15(10):595-596. doi: 10.1038/s41571-018-0065-4. Nat Rev Clin Oncol. 2018. PMID: 29967447 No abstract available.
Cytoreductive nephrectomy for favorable risk patients with metastatic renal cell carcinoma? Yes, cytoreductive nephrectomy should still be considered.
Meza L, Chehrazi-Raffle A, Pal SK. Meza L, et al. Curr Opin Urol. 2020 Sep;30(5):740-742. doi: 10.1097/MOU.0000000000000809. Curr Opin Urol. 2020. PMID: 32732626 No abstract available.
Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma.
Karam JA, Babaian KN, Tannir NM, Matin SF, Wood CG. Karam JA, et al. Minerva Urol Nefrol. 2015 Jun;67(2):149-56. Epub 2015 Feb 3. Minerva Urol Nefrol. 2015. PMID: 25645343 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov